Insider Trading & Ownership of Boxer Capital, LLC

Location
San Diego, CA
Summary
The estimated value of insider holdings of Boxer Capital, LLC is at least $293,244,500 dollars as of 14 May 2024. Boxer Capital, LLC is the Other* of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $139.49M. Boxer Capital, LLC is the Other* of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $94.19M. Boxer Capital, LLC is the Other* of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $51.57M. Boxer Capital, LLC is the 10%+ Owner of Odonate Therapeutics, Inc. and owns shares of Odonate Therapeutics, Inc. stock worth about $6.6M. Boxer Capital, LLC is the Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc. of Rain Oncology Inc. and owns shares of Rain Oncology Inc. stock worth about $1.39M.
Signature
/s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
All Insider Reports
All Insider Reports

Notify me when Boxer Capital, LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Boxer Capital, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TNGX Tango Therapeutics, Inc. Other* $139,494,711 13 Oct 2023
TYRA Tyra Biosciences, Inc. Other* $94,186,205 06 Feb 2024
ITOS iTeos Therapeutics, Inc. Other* $51,571,013 10 May 2024
ODT Odonate Therapeutics, Inc. 10%+ Owner $6,598,394 22 Nov 2021
RAIN Rain Oncology Inc. Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc. $1,394,177 22 May 2023
MRTX Mirati Therapeutics, Inc. Other* 23 Jan 2024

Insider Transactions Reported by Boxer Capital, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.